Table 2.

Postoperative outcomes

Outcomes	DXM (n = 52)	N-DXM (n = 40)	P
Pain score on the second day	3.60 ± 0.21	4.83 ± 0.32	0.001
Postoperative hospital stay, days	6.21 ± 0.44	6.48 ± 0.36	0.658
Postoperative adverse events, n (%)			0.313
Adverse cardiac events	0	3 (7.5)
Adverse cerebrovascular events	1 (1.9)	0
3-month follow-up, n (%)			0.718
Type I endoleak	0	1 (2.5)
Type II endoleak	1 (1.9)	1 (2.5)

DXM dexamethasone group, N-DXM non-dexamethasone group